Search Results - "Remington, Lance"
-
1
A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors
Published in Frontiers in immunology (12-12-2023)“…Immune checkpoint therapies have led to significant breakthroughs in cancer patient treatment in recent years. However, their efficiency is variable, and…”
Get full text
Journal Article -
2
Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors
Published in Frontiers in immunology (2024)“…[This corrects the article DOI: 10.3389/fimmu.2023.1311658.]…”
Get full text
Journal Article -
3
Abstract 1637: A fully human anti-vista antibody as a promising therapy against poorly immunogenic tumors
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract V-domain Immunoglobulin Suppressor of T cell Activation (VISTA/PD-1H) is an immune checkpoint regulator of the B7 family. VISTA can be found on the…”
Get full text
Journal Article -
4
Abstract 4261: CD27 a new immuno-oncology target shaping innate and adaptive anti-tumor immune responses
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract CD27 is a member of the TNF-receptor superfamily, highly expressed on CD4+ and CD8+ T cells as well as on NK and NKT cells. It plays a key role on T…”
Get full text
Journal Article -
5
Abstract 972: VISTA expression in patients with advanced solid tumors: A potential biomarker in VISTA-101 clinical trial
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract V-domain Immunoglobulin Suppressor of T cell Activation (VISTA/PD-1H) is a B7 family member highly expressed on circulating and intra-tumoral myeloid…”
Get full text
Journal Article -
6
182 Highly potent fully human anti-VISTA antibodies – a new target checkpoint inhibitor against immunosuppressive myeloid cells
Published in Journal for immunotherapy of cancer (01-11-2020)“…BackgroundV-domain Immunoglobulin Suppressor of T cell Activation (VISTA/PD-1H) is a B7 family ligand expressed on circulating and intratumoural myeloid cells…”
Get full text
Journal Article